Tag: Wesana Health - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article Wesana Health Announces Closing of Previously Announced SANA-013 Asset Sale

Wesana Health Announces Closing of Previously Announced SANA-013 Asset Sale

Post published:July 5, 2023
Post category:Press Release

Read more about the article Wesana Health Announces Voting Results of AGSM

Wesana Health Announces Voting Results of AGSM

Post published:June 9, 2023
Post category:Press Release

Read more about the article Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery

Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery

Post published:March 21, 2023
Post category:Press Release

Read more about the article Wesana Health Announces Receipt of Short-Term Loan

Wesana Health Announces Receipt of Short-Term Loan

Post published:December 21, 2022
Post category:Press Release

Read more about the article Wesana Announces Sale of Clinic Management Services Organization

Wesana Announces Sale of Clinic Management Services Organization

Post published:September 3, 2022
Post category:Press Release

Read more about the article Wesana Announces Second Quarter 2022 Financial Results

Wesana Announces Second Quarter 2022 Financial Results

Post published:August 30, 2022
Post category:Press Release

Read more about the article Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

Post published:June 8, 2022
Post category:Press Release

Read more about the article Wesana Health Provides Strategic and Operational Updates

Wesana Health Provides Strategic and Operational Updates

Post published:January 12, 2022
Post category:Press Release

Read more about the article Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

Post published:January 11, 2022
Post category:Press Release

Read more about the article MAPS and Wesana Health Resume Negotiations

MAPS and Wesana Health Resume Negotiations

Post published:December 14, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.